Bridget Wilcken

Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.

B. Wilcken, V. Wiley, G. Sherry, 1995, The Journal of pediatrics.

Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.

B. Wilcken, K. Gaskin, D. Waters, 1990, The New England journal of medicine.

Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.

P. V. van Asperen, B. Wilcken, V. Wiley, 2000, The Journal of pediatrics.

The mild form of menkes disease: a 34 year progress report on the original case.

Bridget Wilcken, John Christodoulou, Michel Tchan, 2013, JIMD reports.

Screening for disease in the newborn: the evidence base for blood-spot screening.

B. Wilcken, Bridget Wilcken, 2012, Pathology.

Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia

B. Wilcken, V. Wiley, K. Carpenter, 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.